Targeting of gene expression by siRNA in CML primary cells
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- buněčné kultury MeSH
- buňky K562 MeSH
- chronická myeloidní leukemie genetika patologie MeSH
- dospělí MeSH
- exprese genu účinky léků MeSH
- lidé středního věku MeSH
- lidé MeSH
- malá interferující RNA farmakologie MeSH
- nádorové buňky kultivované MeSH
- RNA interference * MeSH
- sekvenční analýza hybridizací s uspořádaným souborem oligonukleotidů MeSH
- senioři MeSH
- transfekce MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- malá interferující RNA MeSH
Development of array methods contributes to elucidation of many genes expressed during oncogenesis. Our array-based analyses of gene expression in patients with chronic myeloid leukemia (CML) revealed several genes (MMP8, MMP9, PCNA, JNK2, MAPK p38) with significant increased expression. We suppose that the genes may be implicated in the disease development and a siRNA-suppression can elucidate their functions in leukemogenesis. One of the crucial requirements for this purpose is a high efficiency of siRNA delivery into CML primary cells. Using fluorescein-labeled siRNAs we systematically tested a variety of physical and chemical non-vector based transfection methods in order to evaluate which of them gave the most suitable transfer. Chemically synthesized siRNAs against mentioned genes were transfected into the cells and level of knockdown was determined by real time RT-PCR. Chemical transfection reagents (Oligofectamine, Metafectene, siPORT Amine) commonly used to transfect siRNAs in CML cell lines showed very low siRNA delivery in CML primary cells-mRNA levels decreased at the most to 76%. Electroporation achieved better results (suppression to 63%) but it was associated with high degree of cell death (more than 60%). In the study we obtained the best transfection efficiency using nucleofector technology. Gene expressions ranged 22-37% that remained from original levels. According to our results, nucleofection appears to be the only suitable non-viral method for siRNA delivery into the hard-to-transfect CML primary cells.
Zobrazit více v PubMed
Oligonucleotides. 2003;13(5):375-80 PubMed
Tissue Eng. 2002 Apr;8(2):235-45 PubMed
Blood. 2000 Nov 15;96(10):3343-56 PubMed
Br J Haematol. 2005 May;129(3):377-80 PubMed
J Cell Sci. 2003 Aug 1;116(Pt 15):3051-60 PubMed
J Biol Chem. 2003 Sep 19;278(38):36537-46 PubMed
Leuk Lymphoma. 1993 Jul;10(4-5):265-71 PubMed
Nat Rev Mol Cell Biol. 2003 Jun;4(6):457-67 PubMed
Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11746-50 PubMed
Clin Exp Metastasis. 1999;17(7):631-9 PubMed
Mod Pathol. 1997 Feb;10(2):91-7 PubMed
Blood. 2003 Feb 15;101(4):1566-9 PubMed
Oncol Res. 1993;5(1):19-28 PubMed
Cancer Cell. 2002 Oct;2(4):289-300 PubMed
Cas Lek Cesk. 2000 Oct 25;139(21):655-9 PubMed
Leuk Lymphoma. 2002 Jun;43(6):1289-95 PubMed
J Biol Chem. 2001 Jul 27;276(30):28570-7 PubMed
Cytokines Cell Mol Ther. 2000 Sep;6(3):127-34 PubMed
Cas Lek Cesk. 2005;144(7):472-5 PubMed
Br J Haematol. 2004 Apr;125(2):128-40 PubMed
Cell Biol Int. 1994 Sep;18(9):869-74 PubMed
Eur Cytokine Netw. 2005 Sep;16(3):223-32 PubMed
